NONMEM Users Network Archive

Hosted by Cognigen

Stockholm Uppsala Pharmacometrics meeting April 15th

From: Mats Karlsson <Mats.Karlsson>
Date: Tue, 17 Mar 2015 13:49:07 +0000

Dear Colleagues,

On April 15 a recently formed local interest group, "Stockholm Uppsala Phar=
macometrics" (SUP) will have its first meeting. We hope to create an opport=
unity for sharing experiences, problems and solutions between pharmacometri=
cians and other interested parties from industry, academia, hospitals and r=
egulatory agencies.

Venue: Lecture Hall B42, Biomedical Centre, Uppsala University, Uppsala, Sw=

Time: 13:00-17.30, April 15th

Registration Fee: None

Registration: Please notify Marie Sandström (marie.sandstrom
d also if you plan to join for a dinner afterwards (starting at 18.00 at a =
local restaurant - at your own expense)

Program topic: "Biologics"

PK/PD of trastuzumab emtansine (T-DM1): an antibody-drug conjugate for the =
treatment of HER2-positive cancer

Brendan Bender, Genentech/Uppsala University

Gyrolab - an automated, nanoliter-scale Immunoassay Platform suitable for b=
ioanalysis of Biologics

Ann-Charlott Steffen, Gyros AB

The Affibody-Albumod technology; a biologic drug platform with diversified =
PKPD options

Anders Wennborg, Affibody AB


A unique study design for evaluation of a novel immunotherapy for Alzheimer=
's Disease

Gunilla Osswald, BioarcticNeuroscience AB

The potential for modeling and simulation in the development of biosimilar =

Jacob Brogren, Qpharmetra

A time-to-event model for the immunogenicity of certolizumab pegol in rheum=
atoid arthritis subjects

Mats Karlsson, Uppsala University

Sofia Friberg Hietala
Fredrik Jonsson
Mats Karlsson
Marie Sandström
Janet Wade
Johan Wallin

Mats Karlsson, PhD
Professor of Pharmacometrics

Dept of Pharmaceutical Biosciences
Faculty of Pharmacy
Uppsala University
Box 591
75124 Uppsala

Phone: +46 18 4714105
Fax + 46 18 4714003<http://www.farmb=>

Received on Tue Mar 17 2015 - 09:49:07 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: